Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

310 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Proton pump inhibitors and osteoporosis.
Andersen BN, Johansen PB, Abrahamsen B. Andersen BN, et al. Among authors: abrahamsen b. Curr Opin Rheumatol. 2016 Jul;28(4):420-5. doi: 10.1097/BOR.0000000000000291. Curr Opin Rheumatol. 2016. PMID: 27224743 Review.
Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.
Abrahamsen B, Stilgren LS, Hermann AP, Tofteng CL, Bärenholdt O, Vestergaard P, Brot C, Nielsen SP. Abrahamsen B, et al. J Bone Miner Res. 2001 Jul;16(7):1212-9. doi: 10.1359/jbmr.2001.16.7.1212. J Bone Miner Res. 2001. PMID: 11450696
A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
Abrahamsen B, Madsen JS, Tofteng CL, Stilgren L, Bladbjerg EM, Kristensen SR, Brixen K, Mosekilde L. Abrahamsen B, et al. J Bone Miner Res. 2003 Apr;18(4):723-9. doi: 10.1359/jbmr.2003.18.4.723. J Bone Miner Res. 2003. PMID: 12674333
Adverse effects of bisphosphonates.
Abrahamsen B. Abrahamsen B. Calcif Tissue Int. 2010 Jun;86(6):421-35. doi: 10.1007/s00223-010-9364-1. Epub 2010 Apr 21. Calcif Tissue Int. 2010. PMID: 20407762 Review.
310 results